Abstract Details

Title Plasma Levels of Neurofilament Heavy Subunit (NF-H) Are Increased in ALS Patients; Correlation with Site of Onset and Survival in Patients at 2 Centers in Evaluation of Plasma NF-H as a Potential ALS Biomarker

Topic Anterior Horn

Presentation(s) (-)

Poster/Presentation
Number 233

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Kevin B. Boylan, MD	No disclosure on file
Jonathan D. Glass, MD (Emory University School of Medicine)	Dr. Glass has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Glass has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apic Bio. Dr. Glass has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CIRM. Dr. Glass has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bryan Cave Leighton Paisner. The institution of Dr. Glass has received research support from NIH. The institution of Dr. Glass has received research support from ALS Assoiciation. The institution of Dr. Glass has received research support from Muscular Dystrophy Assoication.
Cui Yang, MD (Kaiser Permanente)	No disclosure on file
Kailie Luan, MD (Alberta Health Services)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��